CUPRIC CHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cupric Chloride, and what generic alternatives are available?
Cupric Chloride is a drug marketed by Exela Pharma and Hospira and is included in two NDAs.
The generic ingredient in CUPRIC CHLORIDE is cupric chloride. Two suppliers are listed for this compound. Additional details are available on the cupric chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cupric Chloride
A generic version of CUPRIC CHLORIDE was approved as cupric chloride by EXELA PHARMA on October 31st, 2022.
Summary for CUPRIC CHLORIDE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 52 |
Patent Applications: | 92 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CUPRIC CHLORIDE at DailyMed |
US Patents and Regulatory Information for CUPRIC CHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Exela Pharma | CUPRIC CHLORIDE | cupric chloride | INJECTABLE;INJECTION | 212071-001 | Oct 31, 2022 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Hospira | CUPRIC CHLORIDE IN PLASTIC CONTAINER | cupric chloride | INJECTABLE;INJECTION | 018960-001 | Jun 26, 1986 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |